Syngene International Limited (BOM:539268)

Market Cap	286.41B
Revenue (ttm)	35.41B
Net Income (ttm)	5.02B
Shares Out	n/a
EPS (ttm)	12.48
PE Ratio	57.11
Forward PE	n/a
Dividend	1.25 (0.17%)
Ex-Dividend Date	Jun 28, 2024

Volume	8,607
Average Volume	101,847
Open	747.90
Previous Close	745.15
Day's Range	721.80 - 747.90
52-Week Range	608.00 - 960.00
Beta	n/a
RSI	34.96
Earnings Date	Apr 24, 2025

About Syngene International

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, prot...

• Industry: Commercial Physical and Biological Research
• Founded: 1993
• Employees: 6,510
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539268

Financial Performance

In 2023, Syngene International's revenue was 34.89 billion, an increase of 9.26% compared to the previous year's 31.93 billion. Earnings were 5.10 billion, an increase of 9.82%.